AE Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Buy
16,924
+2,063
+14% +$27.8K ﹤0.01% 1519
2025
Q4
$167K Buy
14,861
+2,019
+16% +$23.1K ﹤0.01% 1559
2025
Q3
$148K Buy
+12,842
New +$150K ﹤0.01% 1466

Other funds holding AVNS

AE Wealth Management's AVNS Position: Q1 2026 in Review

AE Wealth Management increased its Avanos Medical (AVNS) stake by 14% in Q1 2026, buying an estimated $27.8K and bringing the position to 16,924 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

AE Wealth Management first reported a position in AVNS in Q3 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • AE Wealth Management held 16,924 shares of Avanos Medical worth $237K as of Q1 2026.
  • AE Wealth Management bought 2,063 Avanos Medical shares in Q1 2026, an estimated $27.8K.
  • Avanos Medical made up ﹤0.01% of AE Wealth Management's portfolio in Q1 2026, its #1519 holding.
  • AE Wealth Management first reported a position in Avanos Medical in Q3 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.